Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2800 of 3546 entries
View as:

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01494532 Org: User:
Start: 04/02/12 End: 11/18/14 Due: 11/18/15

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02075463 Org: User:
Start: 06/01/14 End: 03/16/16 Due: 03/16/17

A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT03261167 Org: User:
Start: 08/02/17 End: 01/10/19 Due: 01/10/20

A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04813354 Org: User:
Start: 04/14/21 End: 07/08/21 Due: 07/08/22

A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00404963 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

Paxil CR Bioequivalence Study Brazil - Fed Administration

Phase: N/A Priority: Normal
NCT ID: NCT01339247 Org: User:
Start: 10/20/09 End: 11/16/09 Due: 11/16/10

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00196963 Org: User:
Start: 03/31/05 End: 07/31/05 Due: 07/31/06

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

Phase: N/A Priority: Normal
NCT ID: NCT00532077 Org: User:
Start: 08/31/07 End: 01/31/08 Due: 01/31/09

A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01137994 Org: User:
Start: 10/31/11 End: 03/31/18 Due: 03/31/19

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT04604795 Org: User:
Start: 11/04/20 End: 06/29/21 Due: 06/29/22

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00387127 Org: User:
Start: 11/30/06 End: 01/31/14 Due: 01/31/15

A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00849329 Org: User:
Start: 03/10/09 End: 11/24/09 Due: 11/24/10

A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01738451 Org: User:
Start: 01/22/13 End: 11/28/14 Due: 11/28/15

A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT03361774 Org: User:
Start: 10/01/18 End: 12/03/18 Due: 12/03/19

Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00158873 Org: User:
Start: 09/30/04 End: - Due: -

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Phase: N/A Priority: Normal
NCT ID: NCT05660265 Org: User:
Start: 08/26/23 End: 02/06/26 Due: 02/06/27

An Extension to Study MD7108240

Phase: N/A Priority: Normal
NCT ID: NCT00733304 Org: User:
Start: 06/25/08 End: 09/09/09 Due: 09/09/10

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT00307528 Org: User:
Start: 01/20/04 End: 03/30/05 Due: 03/30/06

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00549328 Org: User:
Start: 02/29/08 End: 04/30/09 Due: 04/30/10

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00127010 Org: User:
Start: 11/30/05 End: 06/30/06 Due: 06/30/07

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01039675 Org: User:
Start: 01/01/10 End: 04/20/10 Due: 04/20/11

Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00448435 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

First Study in Humans With GSK206136

Phase: N/A Priority: Normal
NCT ID: NCT01059578 Org: User:
Start: 05/23/06 End: 12/18/06 Due: 12/18/07

Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00067457 Org: User:
Start: 06/30/03 End: 12/31/05 Due: 12/31/06

The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03363191 Org: User:
Start: 03/07/18 End: 05/29/19 Due: 05/29/20